RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-induced psychosis
Accession: DOID:8646
browse the term
Definition: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Synonyms: exact_synonym: Drug Psychoses; Toxic Psychoses; substance-induced psychoses
primary_id: MESH:D011605 ; RDO:0006434
xref: ICD9CM:293.89
For additional species annotation, visit the
Alliance of Genome Resources .
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr22:5,233,876...5,248,622
Ensembl chr22:22,104,253...22,114,189
G
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr 7:44,930,859...45,040,078
Ensembl chr 7:45,001,267...45,110,342
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 6:149,507,599...149,918,523
Ensembl chr 6:154,317,002...154,631,551
G
GRM2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 3:51,639,792...51,652,779
Ensembl chr 3:52,873,144...52,884,395
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 5:50,045,266...50,049,636
Ensembl chr 5:51,692,416...51,693,684
G
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 1:18,619,683...18,635,822
Ensembl chr 1:19,662,978...19,678,680
G
NPY1R
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 4:155,583,870...155,604,336
Ensembl chr 4:167,372,310...167,381,597
G
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 6:151,827,323...151,937,658
Ensembl chr 6:156,517,661...157,088,251
G
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr17:8,189,555...8,200,491
Ensembl chr17:8,175,968...8,186,790
G
PICK1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
Ensembl chr22:36,796,015...36,814,469
G
RGS9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr17:59,085,707...59,176,368
Ensembl chr17:64,262,585...64,389,559
G
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
Ensembl chr 5:1,437,567...1,488,829
G
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:82,018,585...82,132,938
Ensembl chr 4:92,737,608...92,850,600
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:109,343,020...109,385,060
Ensembl chr12:112,734,243...112,776,471
G
ANKK1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:108,267,717...108,280,635
Ensembl chr11:112,111,003...112,123,382
G
DRD2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:60,364,466...60,372,147
Ensembl chr X:70,422,504...70,429,971
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:109,756,303...109,978,510
Ensembl chr12:113,151,017...113,311,809
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ANK3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:56,560,589...57,269,952
Ensembl chr10:58,790,696...59,602,954
G
ARHGEF10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:5,381,357...5,541,094
Ensembl chr 8:1,724,413...1,862,917
G
RPS6KA1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 1:25,792,428...25,837,950
Ensembl chr 1:26,856,057...26,900,532
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
HTR2A
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr13:27,976,415...28,042,941
Ensembl chr13:46,694,273...46,759,826
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr17:4,766,616...4,777,253
Ensembl chr17:4,757,048...4,767,517
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
GAD1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chr2B:58,100,623...58,145,045
Ensembl chr2B:175,558,538...175,602,944
G
GAD2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr10:26,392,877...26,481,859
Ensembl chr10:26,759,243...26,843,197
G
OPRM1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 6:151,827,323...151,937,658
Ensembl chr 6:156,517,661...157,088,251
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ANK3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:56,560,589...57,269,952
Ensembl chr10:58,790,696...59,602,954
G
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr20:3,169,094...3,172,900
G
BPIFA1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:29,524,619...29,532,996
Ensembl chr20:30,642,191...30,649,515
G
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr17:11,261,435...11,313,630
Ensembl chr17:11,650,057...11,701,208
G
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr14:82,188,126...82,190,220
G
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:9,681,847...9,745,334
Ensembl chr19:10,342,478...10,406,972
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:29,049,993...29,096,957
Ensembl chr20:30,186,069...30,215,487
G
DRD2
dopamine receptor D2
ISO
mRNA:decreased expression: pituitary gland (rat) DNA:Hypermethylation:promoter
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:31,542,946...31,560,894
Ensembl chr 6:32,429,271...32,451,844
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
sexual_dimorphism treatment
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chr15:3,129,481...3,357,495
Ensembl chr15:23,981,359...24,058,357
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 5:157,436,113...157,529,586
Ensembl chr 5:164,068,122...164,222,179
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chr12:13,543,104...13,987,437
Ensembl chr12:13,969,387...14,388,799
G
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:111,731,139...111,761,826
Ensembl chr 6:115,802,367...115,833,004
G
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr2B:126,287,745...126,649,815
Ensembl chr2B:245,123,061...245,427,054
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr16:47,776,118...47,782,861
Ensembl chr16:67,165,215...67,171,417
G
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:77,332,926...77,648,474
Ensembl chr15:96,535,164...96,832,974
G
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr2A:85,589,301...85,595,437
Ensembl chr2A:87,141,857...87,148,322
G
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chr X:143,571,864...143,647,192
Ensembl chr X:153,465,204...153,527,854
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 1:212,353,195...212,463,304
Ensembl chr 1:217,358,050...217,460,946
G
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:114,784,232...114,938,385
Ensembl chr12:118,163,655...118,314,005
G
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 4:140,418,624...140,785,180
Ensembl chr 4:152,108,508...152,430,298
G
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:49,650,844...49,677,494
Ensembl chr 8:47,029,313...47,056,577
G
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
Ensembl chr20:62,004,176...62,017,866
G
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr20:2,092,171...2,108,141
Ensembl chr20:1,856,850...1,872,452
G
PER2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr2B:125,477,021...125,521,577
Ensembl chr2B:244,328,122...244,371,040
G
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:27,596,413...27,622,844
Ensembl chr 8:24,796,638...24,822,758
G
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
G
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 6:22,109,974...22,125,433
Ensembl chr 6:22,450,132...22,459,829
G
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:57,933,152...58,063,824
Ensembl chr15:76,891,556...77,022,534
G
RPS6KA1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:25,792,428...25,837,950
Ensembl chr 1:26,856,057...26,900,532
G
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 4:131,869,999...131,921,342
Ensembl chr 4:143,167,190...143,227,732
G
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr2B:59,071,123...59,297,327
Ensembl chr2B:176,532,940...176,641,894
G
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:26,546,177...26,572,301
Ensembl chr17:27,050,900...27,092,882
G
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:4,494,029...4,595,415
Ensembl chr15:22,747,075...22,825,459
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,282,009...49,339,887
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:145,722,475...145,767,550
Ensembl chr 3:153,341,947...153,345,380
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
APP
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chr21:12,324,455...12,608,594
Ensembl chr21:25,684,355...25,995,072
G
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr11:112,120,950...112,151,505
Ensembl chr11:116,054,303...116,084,812
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
BDNF
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chr2B:94,762,796...94,836,304
Ensembl chr2B:212,891,261...212,958,130
G
GDNF
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chr 5:72,539,374...72,566,918
Ensembl chr 5:77,577,313...77,601,362
G
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr13:11,737,942...11,894,923
Ensembl chr13:30,174,899...30,179,527
G
IGF1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IGFBP7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 4:66,808,845...66,888,301
Ensembl chr 4:73,382,745...73,462,087
G
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chr 7:23,415,922...23,420,767
G
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr15:57,367,314...57,430,322
Ensembl chr15:76,331,610...76,394,476
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr22:3,883,119...3,990,368
Ensembl chr22:20,365,487...20,450,335
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
Ensembl chr16:30,489,362...30,498,017
G
NGF
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chr 1:87,223,597...87,276,759
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
G
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 4:140,418,624...140,785,180
Ensembl chr 4:152,108,508...152,430,298
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr 9:39,663,986...40,208,770
Ensembl chr 9:84,021,837...84,372,678
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 3:135,685,120...135,867,096
Ensembl chr 3:143,288,563...143,431,314
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ACHE
acetylcholinesterase (Yt blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 7:92,915,065...92,922,079
Ensembl chr 7:106,311,944...106,318,184
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 5:50,045,266...50,049,636
Ensembl chr 5:51,692,416...51,693,684
G
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr12:69,460,883...69,557,329
Ensembl chr12:72,318,908...72,412,557
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all